Infectious Epstein-Barr virus (EBV) specifically induced by one ofthe biologically distinct EBV strains. Studies involving the biological, biochemical, immunological, and oncogenic characteristics require large quantities of infectious virus. Only a few reports (9, 18) on large-scale production of EBV from extracellular fluid are available, and these studies utilized total virus particle counts (VPC) and not virus infectivity to monitor results.
Infectious Epstein-Barr virus (EBV) was produced from suspension cultures of P3HR-1 cells. A protocol for the scaled-up production and concentration of the virus was developed. Virus from the culture fluid was concentrated by continuous-flow pelletization or continuous flow with banding in sucrose. EBV prepared by pelletization yielded 1.7 x 104 infectious units/rnl (10Ox concentration) and <3.4 x 107 EVB particles/ml (1,OOOx concentration), whereas EBV prepared by banding yielded 4.6 x 103 infectious units/ml (10Ox concentration) and 1.3 x 10i EBV particles/ml (1,000X concentration). The majority of the virus particles observed were "empty" membrane-associated particles. A statistical test of the correlation between infectivity and virus particle count was made.
Epstein-Barr virus (EBV), a member of the herpes group of viruses, remains high on the list as a potential cancer-causing virus in humans. Originally the agent was discovered in lymphoblastoid cell cultures from Burkitt's lymphoma (4); however, EBV has been shown to have world-wide distribution and is implicated as the causative agent in infectious mononucleosis, Burkitt's lymphoma, and nasopharyngeal carcinoma. Recent studies by Miller et al. (14) , Klein et al. (11) , and Menezes et al. (13) suggest that different strains of EBV exist. It is important to determine if infectious mononucleosis, Burkitt's lymphoma, and nasopharyngeal carcinoma are specifically induced by one ofthe biologically distinct EBV strains. Studies involving the biological, biochemical, immunological, and oncogenic characteristics require large quantities of infectious virus. Only a few reports (9, 18) on large-scale production of EBV from extracellular fluid are available, and these studies utilized total virus particle counts (VPC) and not virus infectivity to monitor results.
This report presents data on the production of EBV from extracellular P3HR-1 fluids in which infectivity as well as VPC were analyzed. The investigation included: (i) P3HR-1 cell growth during inoculum scale-up; (ii) examination of different protocols for concentration of virus; (iii) characterization of virus concentrates by electron microscopy, and infectivity; and (iv) examination of the relationship between infectivity and particle morphology of EBV. 
MATERIALS AND METHODS
Cell cultures. The EBV producer cell line, P3HR-1, a subline of P3J (Jijoye) (8) , used for the production of EBV and Raji cells, was furnished by Gary Pearson (Department of Microbiology, Mayo Clinic, Rochester, Minn.). The P3HR-1 cultures contained 10% immunofluorescent cells for virus capsid antigen (VCA) and produced 10' infectious units/ml (determined by Raji superinfection assay on 10Ox concentrates). P3HR-1 and Raji master stock cultures were frozen and maintained at liquid nitrogen temperature (gas phase). Working stocks of P3HR-1 and Raji cells were prepared by concentration of the master stock 10-fold in growth medium containing 10% dimethyl sulfoxide. One-milliliter samples of the concentrate were frozen at a controlled rate of 1°C/min and stored in liquid nitrogen. In each production scale-up, one ampoule of working stock was used as described in Table 1 . P3HR-1 and Raji cell cultures were grown in RPMI 1640 medium supplemented with L-glutamine (Grand Island Biological Co.), 10% heat-inactivated fetal bovine serum, 100 U of penicillin per ml, and 100,g of streptomycin per ml.
Raji cells were grown in 250 ml of medium in 500- In the CFP method, the culture fluids containing EBV were first filtered through 1.2-and then 0.8-aum filters. After filtration, the culture fluid containing EBV was pelletized by the Szent-Gyorgi and Blum continuous-flow centrifugation at 35,000 x g with a flow rate of 100 ml/min. All virus pellets were collected and resuspended in growth medium at 0.01 or 0.001 of the original volume, dispensed into 1-ml samples, and stored at -70°C. In the CFB method, culture fluids containing EBV were concentrated and partially purified by CFB centrifuge in the RK zonal ultracentrifuge with the RK-3 core (10, 18) .
Immunofluorescence assay. Infectious EBV was determined by superinfection of Raji cells (6) diluted to 5 x 105 cells/ml in T30 flasks containing 5 ml of RPMI 1640 + 10% fetal bovine serum. The cultures were inoculated with appropriate 10-fold dilutions of virus and incubated at 35°C for 4 days. The superinfected cells were removed from the culture medium by centrifugation (200 x g for 10 min), washed with phosphate-buffered saline, spotted on Teflon-coated slides, air dried, and acetone fixed. Human EBV-positive and -negative sera were then applied, fluoresceinlabeled Hyland goat anti-human immunoglobulin was added, and the cells were examined for early antigen by immunofluorescence. The EBV-positive sera were high in VCA and low in early antigen activity as determined by testing with P3HR1 and superinfected Raji cells, respectively. The titer was recorded as the reciprocal of the highest virus dilution giving >0.5% of the cells with positive immunofluorescence when examined for early antigens.
Electron microscopy assay. Virus concentrates were pelleted at 35,000 x g and resuspended in distilled water. Virus was visualized by electron microscopy using the negative stain (NS) technique (15) . In addition to determining the VPC, the morphological types of herpes particles present in a number of the concentrates were tabulated. The critical-point-drying technique (3) was also used to examine the virus concentrates.
RESULTS P3HR-1 cell growth during inoculum scale-up and virus production. The scale-up procedure of P3HR-1 cultures from 1-ml ampoules (working stock) to 6-liter, screw-capped Erlenmeyer flasks is presented in Table 1 . Final production volumes of 36 liters consisted of 12 6-liter Erlenmeyer flasks, each containing 3 liters of P3HR-1 culture fluid. This scale-up procedure consisted of 10 steps requiring a total of 32 days. The incubation temperature was 35°C, flasks were shaken by hand once daily, and the culture medium-air volume ratio was 1:5 for maximum cell growth (19) , with the exception of the 6-liter flask where it was 1:2 (step 10, Table 1 ).
With a decreased culture-air space ratio in ves-EBV PRODUCTION 173 1 1 ml of frozen working stock added to 24 ml of medium in 125-nil flaska.. 25 2 25 ml of inoculum diluted with 25 ml of growth medium in 250-ml flask. 50 3 50 ml of inoculum diluted with 50 ml of growth medium in 500-ml flask. 100 4 100 ml of inoculum diluted with 100 ml of growth medium in 1,000-ml flaskb .200 5 200 ml of inoculum diluted to 600 ml with growth medium and distributed in 200-ml volumes in 3 1-liter flasks 600 6 Each 200 ml of inoculum diluted to 600 ml with growth medium and transferred to 3 3-liter flasks .1,800 7 600 ml of inoculum combined and diluted to 2,400 ml with growth medium and distributed in 200-ml volumes to 12 1-liter flasks .2,400 8 Each 200 ml of inoculum diluted to 600 ml with growth medium and transferred to 12 3-liter flasks .7,200 9 Each 600 ml of inoculum diluted to 1,200 ml with growth medium and transferred to 12 6-liter flasks . 14,400 10 Each 1,200 ml of inoculum diluted to 3,000 ml with growth medium and incubated in 6-liter flasks until harvested .
36,000 a Cultural conditions: Vessel, screw-capped Erlenmeyer flasks, incubated statically except for agitation once every day at 350C; viable cell count was monitored and at cell density of 1 x 106 to 2 x 106 viable cells/ml (3 to 5 days) cultures were diluted to -5 x 106 viable cells/ml; culture-air space ratio 1:5, except in step 10. b Sample of culture removed and tested for VCA, virus infectivity, and presence of mycoplasma. If VCA was <10% and infectivity <103 infectious units/ml or cultures were positive for mycoplasma, the inoculum was discarded and a frozen working stock was initiated. sels other than 7-liter flasks, the P3HR-1 cultures did not survive. The kinetics of cell growth and virus replication in the P3HR-1 culture was established using different sized Erlenmeyer flasks to permit effective scale-up of cells and subsequent maxiimal production of EBV. Growth curves of P3HR-1 cell cultures during culture scale-up (200 ml/i-liter flask) (step 4, Table 1 ) and aging in the 6-liter production flask (3,000 mi/6-liter flask) (step 10, Table 1) Cultures were sampled at indicated times (data points) and cell viability, percentage of VCA-positive cells, and virus infectivity were determined. remained fairly constant throughout the plateau and declining phases of cell growth. Routinely, when cultures reached 1 x 106 to 2 x 106 viable cells/ml, usually at 3 to 5 days post-transfer, they were diluted with fresh media to 5 x 105 viable cells/ml. With less viable cells, the scaleup time would increase. When cell viability fell below 50%, usually at 7 to 10 days, cultures were harvested for virus. Inoculum scale-up was shortened if cultures at step 4 (Table 1) were maintained as working stock and used for subsequent scale-up. In the 6-liter production flasks essentially no cell growth occurred, but the percentage of VCA-positive cells and infectivity remained constant. Culture fluids harvested from the 6-liter cultures after 6 days yielded virus with the least cellular debris, so that subsequent filtration and clarification was simplified. No increase in infectivity was found with longer aging times.
EBV concentration. A typical ultraviolet absorbance profile obtained by CFB is shown in Fig. 2 . Fractions 3 through 15 in the 55 to 25% (wt/vol) sucrose regions (1.257 to 1.103 g/cm3) were pelleted by direct centrifugation in the type 35 rotor at 46,000 x g for 90 min. The distribution of infectivity throughout the gradient is shown in Fig. 3 (Fig. 4a, c , and e). More than half (54%) of all herpes particles counted, using the NS technique, were "empty" membrane-associated particles (Fig. 4b) (5) . The second most frequently observed particles (26%) were naked and "empty" (Fig. 4a) . "Full" particles containing nucleic acid ( Fig. 4b and e) and enveloped particles (Fig. 4c) were rarely observed. The integrity of the envelope as well as the size and shape varied greatly. Using the critical-point drying method, the capsomeres and nucleocapsid structure were well preserved. However, a defined unit membrane envelope was not seen. Instead, an amorphous, fuzzy coat was attached to most particles. The particle size varied with the method used to prepare the specimen. Larger particles with a diameter of 95 to 106 nm were found with the NS technique, whereas with the critical-point drying technique, particles with a diameter of 76 to 82 nm were found. The nucleoid of the herpes particle prepared by critical-point drying (Fig. 4e , arrow, 50 nm) was very similar to that observed in thin sections of P3HR-1 cells (Fig. 4f, a Raji cell superinfection assay using early antigen as indicator of virus infectivity.
b PC using NS method.
c -, EBV particles were not routinely observed.
d Two peaks were obtained from 10 and 50% equal volume (wt/vol) potassium tartrate gradient; the first peak was in the 29 to 32% region, and the second was in the 22 to 26% region. VOL. 35, 1978 tioned P3HR-1 cells which were 10% VCA positive. However, if herpesvirus particles were observed, they were usually immature and trapped in cellular debris.
Correlation coefficients were calculated to estimate the degree of relationship between infectivity and each of the four particle types as demonstrated by NS. In no case did the correlation ofinfectivity with the count of any particle type attain statistical significance (P = <0.05). DISCUSSION P3HR-1 cultures can be scaled-up to large volume using Erlenmeyer flasks without loss of cell viability and proportion of VCA-positive cells. The cultural conditions include static incubation at 35°C, except for agitation once every day and a culture-air space ratio of 1:5. Under these conditions, cultures reached 1 x 106 to 2 x 106 viable cells/ml at 3 to 5 days. At this time cultures contained the highest viability and infectivity titers. Since recovery from frozen ampoules of cells with high viability and high proportions of VCA is variable, maintenance of cultures in 1-liter flasks is advantageous. Virus infectivity appears to be independent of cell viability and growth. Cultures in which the percentage of VCA-positive cells decreased to 5% or less yielded less virus. Virus infectivity increases early in the growth cycle and remains constant through the plateau and decline of growth (Fig. 1 marily immature herpes particles trapped in cellular debris were seen. These observations are similar to those observed by other investigators using P3HR-1 cell lines (12) .
Correlation coefficients were computed for the concentration methods in which virus particles were counted, and in no case did the degree of correlation between infectivity and observed particles attain statistical significance. The lack of correlation between infectivity and particle count could be attributable to the volume of culture fluid being processed, the concentration factor, and the presence of cellular debris. Cellular debris interfered with the counting accuracy, since trapped virus particles are often difficult to visualize. In addition, its presence could affect the spread and adherence of material to the microscope grid. Likewise, no correlation between particle morphology and infectivity was determined, as was demonstrated in the herpes simplex system (16) .
VPC-to-infectious virus ratios obtained from banding methods (Table 2) were approximately 3,000:1. Since VPC were either barely detectable or below 3.4 x 107/ml for the pelletization method, no such ratio can be established for these methods. Data accumulated for herpes simplex virus give a ratio of 10:1 (2). Thus, these data would indicate a need for a more permissive cell system for EBV synthesis, although the P3HR-1 culture can be used and the virus synthesized can be concentrated by a variety of methods.
